Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451 - Roberts, W G; Whalen, P M; Soderstrom, E; Moraski, G; Lyssikatos, J P; Wang, H F; Cooper, B; Baker, D A; Savage, D; Dalvie, D; Atherton, J A; Ralston, S; Szewc, R; Kath, J C; Lin, J; Soderstrom, C; Tkalcevic, G; Cohen, B D; Pollack, V; Barth, W; Hungerford, W; Ung, E (Cancer Res, 2005)